The BIOVF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOVF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The BIOVF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View BIOVF Detailed Price Forecast - CNN Money||View BIOVF Detailed Summary - Google Finance|
|View BIOVF Detailed Summary - Yahoo! Finance||View BIOVF Stock Research & Analysis - Zacks.com|
|View BIOVF Trends & Analysis - Trade-Ideas||View BIOVF Major Holders - Barrons|
|View BIOVF Call Transcripts - NASDAQ||View BIOVF Breaking News & Analysis - Seeking Alpha|
|View BIOVF Annual Report - CompanySpotlight.com||View BIOVF OTC Short Report - OTCShortReport.com|
|View BIOVF Fundamentals - TradeKing||View BIOVF SEC Filings - Bar Chart|
|View Historical Prices for BIOVF - The WSJ||View Performance/Total Return for BIOVF - Morningstar|
|View the Analyst Estimates for BIOVF - MarketWatch||View the Earnings History for BIOVF - CNBC|
|View the BIOVF Earnings - StockMarketWatch||View BIOVF Buy or Sell Recommendations - MacroAxis|
|View the BIOVF Bullish Patterns - American Bulls||View BIOVF Short Pain Metrics - ShortPainBot.com|
|View BIOVF Stock Mentions - StockTwits||View BIOVF Stock Mentions - PennyStockTweets|
|View BIOVF Stock Mentions - Twitter||View BIOVF Investment Forum News - Investor Hub|
|View BIOVF Stock Mentions - Yahoo! Message Board||View BIOVF Stock Mentions - Seeking Alpha|
|View Insider Transactions for BIOVF - SECform4.com||View Insider Transactions for BIOVF - Insider Cow|
|View BIOVF Major Holdings Summary - CNBC||View Insider Disclosure for BIOVF - OTC Markets|
|View Insider Transactions for BIOVF - Yahoo! Finance||View Institutional Holdings for BIOVF - NASDAQ|
|View BIOVF Stock Insight & Charts - FinViz.com||View BIOVF Investment Charts - StockCharts.com|
|View BIOVF Stock Overview & Charts - BarChart||View BIOVF User Generated Charts - Trading View|
Invitation - Presentation of Sobi's Q4/FY 2017 Results
Posted on Tuesday February 13, 2018
STOCKHOLM , Feb. 13, 2018 /PRNewswire/ -- On 22 February, at 08:00 CET , Swedish Orphan Biovitrum AB (publ) (Sobi™) will publish its report for the fourth quarter and full year 2017. Financial analysts ...
The First Patient Enrolled in the ReITIrate Study Evaluating Immune Tolerance Induction With Elocta®
Posted on Thursday October 26, 2017
STOCKHOLM, Oct. 27, 2017 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) announces today that the first patient has been enrolled in the open-label, multicentre ReITIrate study (NCT03103542). The ReITIrate study is designed to investigate the immune tolerance induction (ITI) potential of Elocta® (efmoroctocog alfa) in patients with haemophilia A who have developed inhibitors which have failed to be resolved with other therapies. The development of antibodies (inhibitors) that neutralise the effect of factor VIII is one of the most serious complications to haemophilia A treatment, making standard replacement therapy ineffective, increasing the risk for severe bleeding and morbidity, decreasing quality of life and increasing health care costs[i].
Sobi: Alprolix® Approved in the Kingdom of Saudi Arabia for the Treatment of Haemophilia B
Posted on Tuesday October 24, 2017
STOCKHOLM , Oct. 25, 2017 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that the Saudi Food & Drug Authority (SFDA) in the Kingdom of Saudi Arabia has approved Alprolix® (eftrenonacog ...
Norbert Oppitz Joins Sobi™ as New Senior Vice President, Specialty Care
Posted on Thursday October 05, 2017
STOCKHOLM , Oct. 6, 2017 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) today announces that Norbert Oppitz has been appointed Senior Vice President for the newly established business area ...